Tolvaptan (SAMSCA)

( DrugBank: Tolvaptan / KEGG DRUG: Tolvaptan )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
72	下垂体性ADH分泌異常症	1

72. 下垂体性ADH分泌異常症

臨床試験数 : 41 / 薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04790175 (ClinicalTrials.gov)	March 29, 2021	25/2/2021	Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH	Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in Syndrome of I ...	Antidiuretic Hormone, Inappropriate Secretion	Drug: Tolvaptan (SAMSCA)	Otsuka Pharmaceutical Co., Ltd.	NULL	Recruiting	N/A	N/A	All	300		Japan

First Previous1Next Last